학술논문
One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study
Document Type
Article
Author
Source
In Blood Advances 26 December 2023 7(24):7539-7550
Subject
Language
ISSN
2473-9529